Reply to the comments on: Erlotinib in combination with bevacizumab has potential benefit in non small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials

Many thanks to the researchers ’ interests on our original article [1]. They have raised some issues about our paper mainly concentrating on the accuracy of the selection process, especially for the comparison groups.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research